BayMedica

BayMedica is a profitable biotechnology company that leverages synthetic biology and pharmaceutical chemistry to develop an efficient, scalable, and proprietary platform for producing high-quality, rare cannabinoids for consumer applications and cannabinoid-derived new chemical entities for pharmaceutical applications. Under the leadership of a world-class team, BayMedica is developing highly efficient and scalable biosynthetic biology and synthetic chemistry processes to deliver a range of natural cannabinoids, including CBC, CBN, and CBDV, as well as novel cannabinoid analogs for applications in life sciences, pharmaceuticals, nutraceuticals, cosmetics, and animal health.